Solutions

To consult the local SmPC and Risk Management Plan, please visit our local websites

Austria

French

Germany

Switzerland

UK

Report Adverse Events For PALFORZIA

PALFORZIA® ▼ [Peanut protein as defatted powder from Arachis hypogaea L., semen (peanuts)]

PALFORZIA is indicated for the treatment of patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy. PALFORZIA may be continued in patients 18 years of age and older.

 

▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.

Last updated on: 01/09/2024

Cookies Management